Background and Objectives Multiple sclerosis (MS) often leads to physical, cognitive, and psychological impairments substantially affecting daily functioning and quality of life. Because current disease-modifying therapies do not fully prevent disease progression, interest has grown in the potential role of modifiable...
A. Gravesteijn, I. Nauta, Meike Stob et al.· Neurology· 0 citations
PURPOSE
Longitudinal quantitative data on eye movement abnormalities in people with multiple sclerosis (PwMS) are scarce, and the impact of repeated oculomotor testing on these measures is unknown. We aimed to use infrared oculography to characterise one-year changes in oculomotor metrics in PwMS and to determine wheth...
S. Hof, P. Molenaar, Ka-Hoo Lam et al.· Graefe's archive for clinica...· 0 citations
The longitudinal zNfL changes were related to lesion activity and subsequent atrophy, even after including MRI measures, and cross-sectional zNfL was related to active disease and predictive of disease progression, but not after taking MRI measures into account.
Rozemarijn M. Mattiesing, G. Gentile, M. Battaglini et al.· Journal of Neurology· 0 citations
It is demonstrated that brain-PAD is a clinically meaningful, transdiagnostic biomarker of neurodegeneration that complements conventional volumetric measures like the BPF.
Lonneke Bos, D. V. van Nederpelt, J. Cole et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.